Making the Case for Earlier Palliative Care in PAH: A Clinical Opinion
A clinician shares his experience with palliative care in cardiology and makes the case for offering palliative care services earlier in pulmonary arterial hypertension.
All articles by George Marzouka, MD
FOURIER Trial Data Questions: Are PCSK9 Inhibitors The Right Choice?
Results of the FOURIER trial, presented at the 2017 ACC Scientific Sessions, raise questions about the efficacy of PCSK9 inhibitors as long-term therapy for patients with atherosclerotic CVD.
Should You Agree to Provide Preoperative Cardiology “Clearance”?
A cardiologist contemplates on the value that preoperative “clearance” brings to patients and their surgeons.
Identifying At-Risk Patients Using Coronary Artery Calcium Scores
Researchers argue that elevated coronary artery calcium scores increase the risk of adverse cardiovascular events even in young patients.
-
Loading...
-
Loading...
Next post in CHD
